Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × sintilimab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 8 Colorectal Neoplasms 6 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Rectal Neoplasms 2 Neoplasm Metastasis 2 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Resectable NSCLC 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 13 Cisplatin 13 durvalumab 10 Leucovorin 7 pembrolizumab 6 Fluorouracil 6 Oxaliplatin 5 Nivolumab 5 lenvatinib 4 Capecitabine 4 Bevacizumab 4 irinotecan sucrosofate 3 S 1 (combination) 3 Liquid Biopsy 3 Injections 3 Carboplatin 3 Tegafur 2 Itraconazole 2 Irinotecan 2 Folfox protocol 2 Albumin-Bound Paclitaxel 2 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tislelizumab 1 pertuzumab 1 mitazalimab 1 gemcitabine-oxaliplatin regimen 1 envafolimab 1 brigimadlin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡